Arizona Cancer Center
Arizona Cancer Center
Cancer Specialties: The Arizona Cancer Center at UMC North sees patients with a range of conditions and care needs
Primary location:
1501 N. Campbell Ave.
Tucson, Arizona 85719-1454
Phone: (520) 694 – 2873
URL: www.azcc.arizona.edu
Facebook: http://www.facebook.com/arizonacancercenter
Twitter: http://twitter.com/AZCancerCenter
About the Arizona Mesothelioma Cancer Center:
Initially founded in 1976 as a Division of the University of Arizona’s College of Medicine, the Arizona Cancer Center currently stands as Center of Excellence in the Arizona Health Sciences Center. In 1990, the Arizona Cancer Center was designated as one of the first comprehensive cancer centers by the National Cancer Institute (NCI). The Arizona Cancer Center is one of only two comprehensive cancer centers within the five-state region of Arizona, Colorado, Nevada, New Mexico, and Utah.
The primary responsibility of an NCI comprehensive cancer center is to conduct research that will lead to the reduction of cancer morbidity and mortality. A framework for this research consists of focusing upon the molecular and cellular mechanisms of oncogenesis. Molecular mechanisms emphasize genetic, epigenetic, and signaling mechanisms, while cellular mechanisms emphasize the biology of invasion and metastasis, as well as stromal-cellular interactions. With the primacy of this research mission in mind, the research programs and core services constitute a bedrock of the Arizona Cancer Center.
Overall, the Arizona Cancer Center has five scientific research programs that work together to accomplish the Center’s mission to prevent and cure cancer:
Cancer Biology and Genetics;
Cancer Imaging;
Cancer Prevention and Control;
Gastrointestinal Cancer; and
Therapeutic Development.
These five research programs collaborate concerning a breadth of issues from benchtop to bedside involving translational and clinical research with a major emphasis on discovery. Furthermore, these programs also focus on the development and delivery of novel treatments to reduce the morbidity and mortality of cancer in the Southwest and across the nation.
